Peroxisome proliferator-activated receptor alpha  Wy-14,643  Bile acid homeostasis  Farnesoid X receptor  Metabolomics  

active zone stability  Drosophila  neuromuscular junction  dephosphorylation  Liprin-α  Syd-1  PP2A  GSK-3?  living scaffolds  neural tissue engineering  cell transplant  biomaterials  regeneration  neurotrauma  neurodegeneration  axon pathfinding  cell migration  injury  plasticity  neurodegenerative disease  brain  therapy  neuron  microglia  neural progenitor  tissue engineering  neuroregeneration  repair  central nervous system  biomaterial  regenerative medicine  nanotechnology  spinal cord injury  axonal regeneration  exosome  extracellular vesicle  microRNA  microvesicle  nerve gap  neurite outgrowth  peripheral nerve injury  Schwann cell  stem cell  hemodynamic phases  cerebral subarachnoid hemorrhage  metabolic crises  nerve regeneration  hypoxic-ischemic brain damage  ginsenoside Rg1  neural stem cells  cell transplantation  cell differentiation  cognition  nerve reconstruction  neural regeneration  nerve regeneration  brain injury  neuroimaging  functional magnetic resonance imaging  regional homogeneity  apoplexy  subacute  ischemia  participants  healthy  volunteers  brain activity  NSFC grants  neural regeneration  nerve regeneration  brain injury  neuroprotection  cerebral ischemia/reperfusion injury  lateral intracerebroventricular injection  Apelin-13  nerve apoptosis  Bcl-2  caspase-3  NSFC grants  neural regeneration  nerve regeneration  fractalkine  CX3 chemokine receptor 1  neuronal maturation  dendrites  doublecortin  synaptic maturation  newborn neurons  neural regeneration  nerve regeneration  neurodegenerative diseases  Alzheimer′s disease  transgenic animal models  mice  epimedium herb  milkvetch root  kudzuvine root  divalent metal transporter 1  ferroportin 1  neural regeneration  nerve regeneration  microRNA-124  neurogenesis  neuronal survival  Huntington′s disease  SRY-related HMG box transcription factor 9  brain-derived neurotrophic factor  peroxisome proliferator-activated receptor gamma coactivator 1-alpha  mutant huntingtin  nerve regeneration  Ras/Raf/Erk1/2 signaling pathway  spinal cord injury  apoptosis  repair  regulation  inhibition  neural regeneration  nerve regeneration  neurogenic bladder  bibliometric analysis  Web of Science database  visualization analysis  CiteSpace III  citation analysis  neural regeneration  nerve regeneration  sciatic nerve injury  autologous nerve grafting  epineurial suturing  three-dimensional finite element models  load  stress  displacement  neural regeneration  nerve regeneration  brain injury  facial palsy  Bell′s palsy  comparison  methodological quality  therapy  fixed effect model  acupuncture  incomplete recovery  randomized controlled trials  electroacupuncture  NSFC grants  neural regeneration  nerve regeneration  peripheral nerve injury  thalidomide  ankylosing spondylitis  adverse reactions  peripheral neuropathy  treatment  dose  treatment time  age  sex  neural regeneration  Neurology. Diseases of the nervous system  RC346-429  prospective study  

ACTIVATED RECEPTOR-ALPHA  LIVER-GLYCOGEN  STREPTOZOTOCIN  METABONOMICS  METABOLITES  EXTRACT  INSULIN  REPAIR  

5 ' amp-activated protein kinase (ampk)  Fatty acid oxidation  Mitochondrial transcription factor a (tfam)  Mitochondrial dna (mtdna)  Nuclear respiration factors 1 and 2 (nrf1 and nrf2)  Peroxisome proliferator-activated receptor coactivator 1 alpha (ppargc1 alpha)